
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.170 | 3.170 | 0.000 |
Shares | 96.830 | 96.830 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.310 | 15.568 |
Price to Book | 1.495 | 1.907 |
Price to Sales | 0.996 | 1.279 |
Price to Cash Flow | 7.954 | 8.626 |
Dividend Yield | 1.743 | 1.498 |
5 Years Earnings Growth | 9.653 | 11.879 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 20.200 | 17.726 |
Industrials | 19.410 | 19.323 |
Consumer Cyclical | 15.000 | 12.218 |
Technology | 12.870 | 14.553 |
Healthcare | 12.090 | 11.828 |
Basic Materials | 8.870 | 4.845 |
Energy | 4.620 | 4.973 |
Utilities | 3.190 | 2.992 |
Real Estate | 2.980 | 6.721 |
Consumer Defensive | 0.760 | 4.468 |
Number of long holdings: 81
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Valmont Industries | US9202531011 | 3.23 | 269.53 | -2.99% | |
VF | US9182041080 | 3.12 | 10.47 | +0.19% | |
Rev Group | US7495271071 | 3.08 | 29.15 | -2.25% | |
Quidel | US2197981051 | 2.55 | 24.56 | -2.42% | |
AZZ | US0024741045 | 2.51 | 77.62 | -4.17% | |
Ingevity | US45688C1071 | 2.45 | 31.11 | -1.49% | |
Mercury | US5893781089 | 2.38 | 47.24 | -1.50% | |
Adapthealth | US00653Q1022 | 2.25 | 7.33 | -5.91% | |
ICU Medical | US44930G1076 | 2.06 | 136.72 | -1.41% | |
Belden | US0774541066 | 1.95 | 92.21 | -1.93% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Segall Bryant & Hamill Intl Sm Cp I | 69.04M | 7.77 | 3.13 | 4.27 | ||
Westcore Global LC Dividend Retail | 27.53M | 20.87 | 7.72 | 8.45 | ||
Westcore Global LC Dividend Inst | 4.23M | 20.99 | 7.86 | 8.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review